Showing results (21-30 of 192) with videos related to

Sort By:
Pageof 20
Hepatology International|July 23, 2021
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patientsJia-Horng Kao, Wen-Juei Jeng, Qin Ning, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 18, 2015
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patientsChia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, et al.
Journal of Clinical Microbiology|September 8, 2005
Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's diseaseTai-Chung Tseng, Shwu-Jen Liaw, Cheng-Hsiang Hsiao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 19, 2017
Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis BCheng-Hao Tseng, Yao-Chun Hsu, Chi-Yang Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 6, 2020
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in TaiwanHau-Jyun Su, Jia-Horng Kao, Tai-Chung Tseng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2007
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in TaiwanTai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, et al.
Plos One|January 18, 2013
Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patientsHuei-Ru Cheng, Chun-Jen Liu, Tai-Chung Tseng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 22, 2008
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patientsTai-Chung Tseng, Chun-Jen Liu, Chia-Chi Wang, et al.
Pageof 20